Publications

A. Invited Lectures/Articles:

  1. Creighton University Industrial Advisory Board, November 8, 1991, Omaha, Nebraska: "Pharmaceutics and its Role in Drug Delivery Research."
  2. Hanson Research Corporation, May 10, 1993 at Chatsworth, Los Angeles, CA: "Pros and Cons of USP Dissolution Apparatus 3."
  3. Scanning Microscopy 1993 Meeting May 11 to 13 at Los Angeles Airport Hilton Hotel, organized by Scanning Microscopy International: "Scanning Electron Microscopic Studies of Polymeric Microspheres Used as Drug Carriers."
  4. First International Conference on Pharmaceutical Sciences and Technology: "Preparation and Characterization of Implantable Polymeric Drug Delivery Systems for Bone Infections."
  5. Berlex Laboratories August 3, 1993 at Wayne, NJ in association with PMA Coordinated Industry Program for Pharmacy Faculty: "Characterization of Solid-State Properties of Drugs and Dosage Forms."
  6. Pharmaceutical Manufacturers Association Foundation Annual Awardee Meeting, Washington, D.C., January 20, 1994. "Physical state of Drug in Microcapsule and Microspheres Formulations."
  7. College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, March 17, 1994. Methods Used in The Characterization of Solid-State Properties of Drugs and Dosage Forms."
  8. Cells and Materials 1994 Meeting May 7 to May 14 at Ramada Inn, Toronto, Organized by Scanning Microscopy International: "Use of SEM to Study the Effect of Surfactant on the In Vitro Release of Drug from Coated Particles.
  9. College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, December 8, 1994. "Transdermal Drug Delivery Systems.
  10. Agouron Pharmaceuticals, San Diego, California, November 12, 1994."Solid-State Properties and its Importance in Pharmaceutical Research."
  11. Department of Pharmaceutical and Administrative Sciences Seminar, January 18, 1995. "Use of Scanning Electron Microscopy in harmaceutical Research and Development."
  12. Pharmaceutical Research and Manufacturers Association Foundation Annual Awardee Meeting, Washington, D. C., February 10, 1995. "Use of Microdialysis in the Development of Implantable Dosage Forms."
  13. American Association of Pharmaceutical Sciences 10th Annual meeting, Seattle, Washington State, October 29, 1996. “Development and Evaluation of a New Dissolution Method for Implantable Dosage Forms.”
  14. Invited speaker at the Eastern Analytical Symposium, 2001, October 1-4, Atlantic City, NJ. Topic: “Characterization of Solid-State Reaction and its Implications on the Solid-State Properties Using VTXRD, Thermal Analyses and Mass Spectrometry.”
  15. Invited to participate in the Glaxo Wellcome Journal of Innovation in Healthcare “ODYSSEY” (Vol. 6, issue 2, 2000, pp. 58-64) Topic: “Getting Therapeutic Drugs To Their Targets: Special Delivery.”
  16. Invited to Contribute to the Annual Review Volume of Journal of Chromatography B-2002: Title: “Separation Methods Capable to Reveal Blood-Brain Barrier Permeability.”
  17. Invited speaker at the UNMC Department of Oncology and Hematology Grand Rounds, Omaha, NE, Jan 26, 2005. Topic: “Transdermal Delivery of Antiemetics in Cancer Patients.”
  18. Invited speaker at the AAPS Annual Meeting and Exposition, 2006, October 29-November 2, San Antonio, TX. Topic: “Preformulation and its Importance in the Nutraceutical and Sport Supplement Formulations.”
  19. Invited to contribute to the continuing education activity on the topic of antibiotic-associated diarrhea for the Journal Pharmacy Times, 2006.
  20. Invited Speaker at the International Symposium on Nanomedicine, BBSR, India, February 23-25, 2007. Topic: Mucoadhesive In Situ Gel to Nanoparticulate System in the Treatment of Breast Cancer.
  21. Paclitaxel Nanome™ for Breast Cancer Treatment: Development, Characterization, In Vivo Biodistribution, and Tumor Efficacy, Era of Hope, Breast Cancer Meeting, 2011, Department of Defense, Orland, FL, Aug 2-5, 2011.
  22. Surface Modified Solid lipid Nanoparticulate Delivery: Development, Characterization, In Vivo Biodistribution, and Tumor Efficacy of Paclitaxel Nanome™. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, Baltimore, MD, November 9, 2011.
  23. Importance of Science Based Foundational Courses and Critical Thinking Skills in Pharmacy Curriculum, Invited  Plenary Session presenter, First International Conference, Pharmacy Education in the Era of Globalization, January 24-26th, 2012, Nizwa, Oman.
  24. Pharmacy Education in the Era of Globalization”, Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, May 21, 2012, Kuwait City, Kuwait.
  25. Surface Modified Solid-Lipid Nanodelivery: Development, Characterization, In Vivo Biodistribution, and Tumor Efficacy of Paclitaxel Nanome™, Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, May 23, 2012, Kuwait City, Kuwait.
  26. Surface Modified Solid-lipid Nanodelivery: Development, Characterization, In Vivo Biodistribution, and Tumor Efficacy of Paclitaxel Nanome™, University of Nebraska Medical Center. December 7, 2012.
  27. Working with an Expert Witness in Patent Litigation, Global IP conference, Bangalore, India, January 27, 2013.
  28. Nanotechnology in 21st Century Pharmaceutics, Krupanidhi College, Bangalore, India January 28th, 2013.
  29. Surface Modified Solid-Lipid Nanoparticulate Delivery (Paclitaxel Nanome™) for Breast Cancer Treatment, Greater Chicago Land AAPS Meeting, Chicago, Feb 18, 2003.
  30. Surface Modified Solid-Lipid Nanodelivery: Paclitaxel Nanome™. University of Minnesota, Department of Pharmaceutics, Minneapolis: April 4, 2013.
  31. Multi-functional Solid-lipid Nanoparticles for Drug Delivery and Targeting”, Jadavpur University, February 23, 2013.
  32. Nanome™: A Novel Delivery System for Drug Targeting, Misr International University, Cairo, Egypt, March 14, 2013.
  33. Zohydro and the Controversy Surrounding Its Use, Roundtable speaker for The Center for Health Policy and Ethics, Creighton University, August 20, 2014.

B. Abstracts:

  1. Johnson, K. E., Dash, A. K., King, F. E. and Zimmerman, C. L., Etretinate Absorption in the Rat In Situ Intestinal Perfusion Model. Pharm. Res. 3(5), 60S, Oct. 1986.
  2. Dash, A. K. and Suryanarayanan, R., Site Specific Drug Delivery to Treat Bone Infections. AAPS Midwest Meeting, Chicago, May 1989.
  3. Dash, A. K. and Suryanarayanan, R., HPLC Analysis of Tobramycin. AAPS Fourth Annual Meeting, Atlanta, Oct. 1989.
  4. Dash, A. K. and Suryanarayanan, R., Solid State Properties of Tobramycin. AAPS. Fourth Annual Meeting, Atlanta, Oct. 1989.
  5. Dash, A. K. and Suryanarayanan, R., Enhanced Release of Tobramycin from Polydimethylsiloxane (PDMS) Containing Glycerol. AAPS Midwest Meeting, Chicago, May 1990.
  6. Dash, A. K. and Suryanarayanan, R., Comparison of the In Vitro Release Kinetics of Tobramycin from Polymethylmethacrylate (PMMA) and Polydimethylsiloxane (PDMS) Beads. AAPS Annual Meeting, Washington, D.C., 1991.
  7. Dash, A. K., A Simple HPLC Method for the Analysis of Tolnaftate in Pharmaceutical Formulations, AAPS Annual Meeting, San Antonio, TX, 1992.
  8. Dash, A. K., In Vitro Release of Valproic Acid from Coated Particles, AAPS Annual Meeting, San Antonio, TX, 1992.
  9. Dash, A. K., Khin-Khin, A. and Suryanarayanan, R., An X-Ray Powder Diffractometric Method for Quantification of Crystalline Drug in Microcapsules. AAPS Annual Meeting, San Antonio, TX, 1992.
  10. Rossi, A. F., Ichwan, A. M. and Dash, A. K., Development and Evaluation of a Sustained Release Topical Benzocaine Formulation. AAPS Annual Meeting, Orlando, FL, 1993.
  11. Dash, A. K., A Simple LC Method for the Analysis of Pseudoephedrine HCL in Pharmaceutical Formulations. AAPS Annual Meeting, Orlando, FL, 1993.
  12. Junker, S. D. and Dash, A. K., Study of the Physical State of the Drug in Tolnaftate Microspheres and its Effect on In Vitro Release. AAPS Annual Meeting, Orlando, FL, 1993.
  13. Ndyetabula, W. A., Ichwan, A. M. and Dash, A. K., Effect of Surface Tension of the Dissolution Medium on the Release Characteristics of Drug from Coated Particles. AAPS Annual Meeting, Orlando, FL, 1993.
  14. Dash, A. K. Khin-Khin, A. and Suryanarayanan, R., Quantification of Crystalline Drug Content in Microspheres by X-Ray Powder Diffractometry and Differential Scanning Calorimetry. AAPS Annual Meeting, Orlando, FL, 1993.
  15. Dash, A. K., Karimi, M., Use of Gelatin-Acacia Coacervate Containing Benzocaine in Topical Formulation. AAPS Annual Meeting, San Diego, CA, 1994.
  16. Dash, A. K., An Ion-Pair Chromatographic Method for the Analysis of Mafenide Acetate. AAPS Annual Meeting, San Diego, CA, 1994.
  17. Dash, A. K., Haney, P. W., Preparation and Characterization of Rectal Mesalamine Formulation Containing a Bioadhesive. AAPS Annual Meeting, San Diego, CA, 1994.
  18. Dash, A. K., Haney, P. W., Development of an In Vitro Dissolution Method Using Microdialysis Sampling Techniques for Implantable Dosage Forms. AAPS Annual Meeting, San Diego, CA, 1994.
  19. Dash, A. K., Use of Microdialysis in the Development of Implantable Dosage Form, Pharmaceutical Research and Manufacturers Association Foundation Annual Awardee Meeting, Washington, D.C., 1995.
  20. Dash, A. K., Thirucote, R. and Tyle, P., Solid-State Characterization of AG337, a Novel Antitumor Drug. The Sixth International Symposium on Pharmaceutical and Biomedical Analysis, St. Louis, Missouri, 1995.
  21. Dash, A. K., Haney, P. W., Effect of Carbopol on the Stability of 5- Aminosalicylic Acid in Phosphate Buffer. AAPS Annual Meeting, Miami Beach, FL, 1995.
  22. Dash, A. K., Haney, P. W., A Simple LC Method for the Analysis of 5-Aminosalicylic Acid and its Degradation Product. AAPS Annual Meeting, Miami Beach, FL, 1995.
  23. Dash, A. K. and Moster, D., Utilization of Thermoanalytical Methods for the Quantitation of Moisture Absorption by Pharmaceutical Excipients. AAPS Annual Meeting, Miami Beach, FL, 1995.
  24. Dash, A. K. Gong Z. and Wong, S-T., Preparation & Characterization of a Rectal Nicotine Formulation Containing a Bioadhesive. AAPS Annual Meeting, Seattle, Washington, 1996.
  25. Dash, A. K. and Wong, S-T., A Simple LC Method for the Analysis of Nicotine in Pharmaceutical Formulations. AAPS Annual Meeting, Seattle, Washington, 1996.
  26. Dash, A. K., Development and Evaluation of a New Dissolution Method for Implantable Dosage Forms. AAPS Annual Meeting, Seattle, Washington, 1996.
  27. Dash, A.K., D.W. Miller, and Z. Gong, Effect of Formulation Additives on Nicotine Absorption in Caco-2 Cells. Scanning Microscopy 1997 Meeting, Chicago, IL, 1997.
  28. 28.          Kondo, L., Parker, T., Destache, J., Pakiz, C.B., Larson C. and Dash, A.       K., The Role of Nitric Oxide in a Rabbit Model of Streptococcus Pneumoniae (STP) Meningitis, and its Effects on a CSF Cytopathology, Creighton University School of Pharmacy &AHP Poster Session, Spring 1997.
  29. Dash, A. K., Mizo, D. and Ng, R. Effect of Moisture on the Hardness and Disintegration Time of Various Calcium Carbonate Tablets, Creighton University School of Pharmacy & AHP Poster Session, Spring 1997.
  30. Dash, A.K., Halbur, S. and Meimand, D., A Simple LC Method for the Analysis of Ceftriaxone, . AAPS Annual Meeting, Boston, MA,1997.
  31. Destache, J., Pakiz, C.B., Larsen C. and Dash, A. K., Cytopathology and Nitric Oxide (NO) Concentrations in an Experimental Model of Streptococcus pneumonia, AAPS Annual Meeting, Boston, MA,1997.
  32. Dash, A. K., Miller, D., Gong, Z. and Han, H-Y, Effect of Bioadhesives on Nicotine Flux in Caco-2 Cell Monolayers, AAPS Annual Meeting, Boston, MA, 1997.
  33. Dash, A. K., and Zhao, P, Development of An Implantable Drug Delivery System For Targeted Local Delivery Of Anticancer Drug, AAPS Annual Meeting, San Francisco, CA, 1998.
  34. Dash, A. K., and Lori, P, Effect of Penetration Enhancers on the Transport of Nicotine Through Polymeric Membranes, AAPS Annual Meeting, San Francisco, CA, 1998.
  35. Izuegbunam.B. C., Nguyen, E. H., Fausett, H., Gayser Jr., C and Dash, A. K., Development and Evaluation of Quick Release Calcium Carbonate Tablets, AAPS Annual Meeting, New Orleans, LA, 1999.
  36. Pham, H. H., Luo, P., Genin, F., and Dash, A. K., Preparation and Characterization of Hydroxyapatite Microspheres Containing Ciprofloxacin, AAPS Annual Meeting, New Orleans, LA, 1999.
  37. Dash, A.K., Miller, D. W., Huai-Yan, H., Stout, J. R. and Carnazzo, J., Evaluation of the Creatine Monohydrate Permeability Using Caco-2 Monolayers as an In Vitro Model for Intestinal Absorption, AAPS Annual Meeting, New Orleans, LA, 1999.
  38. Destache, C. J., Pakiz, C. B., Larsen, C., Owens, H. and Dash, A. K., Levofloxacin PenetrationInto CSF Using Microdialysis in a Rabbit Model of Pneumococcal Meningitis, AAPS Annual Meeting, New Orleans, LA, 1999.
  39. Johnson, C, Moore, R. and Dash, A. K., Effect of Milk and Other Additives on The Stability of Probiotics in Simulated Gastric Fluid, AAPS Annual Meeting, New Orleans, LA, 1999.
  40. Mo, Y., Carnazzo, J. and Dash, A.K., Solid-State Properties of Creatine Monohydrate, AAPS Annual Meeting, New Orleans, LA, 1999.
  41. Cudworth II, C. and Dash, A. K., Acetic Acid Ester of Monoglycerides as a Suppository Base With Unique Properties, AAPS Annual Meeting, New Orleans, LA, 1999.
  42. Fan, H. and Dash, A. K., In Vitro Release of Doxorubicin from Biodegradable Implants, AAPS Annual Meeting, New Orleans, LA, 1999.
  43. Owens, H., Destache, C. J., Pakiz, C. B., Larsen, and Dash, A. K. Study of the BBB Permeability Charactristics of Various Antibiotics in an Experimental Rabbit Meningitis Model, Creighton University School of Pharmacy &AHP Poster Session, Spring 1999.
  44. Nguyen, D., Khieu, K. and Dash, A.K., Formulation and Evaluation of a Tablet Dosage Form for a Natural Product (Fenugreek), Creighton University School of Pharmacy &AHP Poster Session, Spring 2000.
  45. Nguyen, M., Phothiyane, K. and Dash, A. K., Evaluation and Enhancement of the Stability of an Anti-Cataract Solution, Creighton University School of Pharmacy & AHP Poster Session, Spring 2000.
  46. Chock, A.W.Y., Miller, D. W., Huai-Yan, H., Stout, J. R., Carnazzo, J., Dash, A. K.,The Permeability of Creatine Monohydrate Through Caco-2 Monolayers, Creighton University School of Pharmacy &AHP Poster Session, Spring 2000.
  47. Leighr, J., Neary, P. and Dash, A. K., The Past, Present and Future of Insulin Dosage Forms, Creighton University School of Pharmacy & AHP Poster Session, Spring 2000.
  48. Pham, H. H., Luo, P., Genin, F. and Dash, A. K., Preparation and Characterization of Hydroxyapatite Implants Containing Ciprofloxacin, Creighton University School of Pharmacy &AHP Poster Session, Spring 2000.
  49. Nguyen, H. and Dash, A. K., The In Vitro Release of Nicotine from Two Suppositories Bases, Creighton University School of Pharmacy &AHP Poster Session, Spring 2000.
  50. Pham, H. H., Luo, P., Genin, F. and Dash, A. K., Preparation and Characterization of Novel Drug Delivery Implants for the Treatment of Bone Infections, Sixth World Biomaterials Congress, May 15-20, 2000, Hawaii, USA.
  51. Mo Y., and Dobberpuhl, D. and Dash, A. K., A Simple HPLC Method with Pulsed EC Detection for the Analysis of Creatine and Creatinine in Aqueous and Biological Samples, AAPS Annual Meeting, Indianapolis, IN, 2000.
  52. Nguyen, D. and Dash, A. K., Use of Maltodextrin and Calcium Carbonate Granules in the Formulation of a Tablet Dosage Form for Fenugreek, AAPS Annual Meeting, Indianapolis, IN, 2000.
  53. Dash, A. K., Characterization of Solid-State Reaction and its Implications on the Solid-State Properties Using VTXRD, Thermal Analyses and MS, Eastern Analytical Symposium, 2001, October 1-4, Atlantic City, NJ.
  54. Okpalaeze, G., Okogbaa, J. and Dash, A. K. Usefulness of A-Tab and Di-Tab in Direct Compressed Herbal Formulation. AAPS Annual Meeting, Denver, Colorado, 2001.
  55. Mo, Y., Pyne, A. and Dash, A. K. Thermal Decomposition of Creatine Monohydrate. AAPS Annual Meeting, Denver, Colorado, 2001.
  56. Dash, A. K., A Simple LC Method with UV Detection for the Analysis of Creatine and Creatinine in Formulations. AAPS Annual Meeting, Denver, Colorado, 2001.
  57. Okpalaeze, G., Okogbaa, J., Gayser, C. and Dash, A. K., Use of Ditect Compressed Dried Honey and Molasses in Masking the Strong Odor of Nutraceutical. AAPS Annual Meeting, Denver, Colorado, 2001.
  58. Chigurupati, N., Lani, S., Gayser C. and. Dash, A. K., Evaluation of Red Cabbage Dye as a Potential Natural Color for Pharmaceutical Use. AAPS Annual Meeting, Denver, Colorado, 2001.
  59. Ganguly, S. and Dash A. K., Development of a Novel Biodegradable Gel System for Oral Drug Delivery, Pharmacy Student Research Conference- Western Region; Denver, Colorado, May 31-Jun01, 2002.
  60. Ganguly, S. and Dash A. K., Evaluation of the Solution Stability of Creatine in Large Volume Creatine Supplement Formulations, American Association of Pharmaceutical Scientists Annual Meeting, Toronto, Ontario, Canada, 2002.
  61. Ganguly, S. and Dash A. K., Development of a Novel In Situ Gel System for Oral Drug Delivery, American Association of Pharmaceutical Scientists Annual Meeting, Toronto, Ontario, Canada, 2002.
  62. Adeyemi, O.E., Boyce, A., Saini, T.and Dash, A.K., Development of Novel Polyantibiotic Local Delivery System for Intracrevicular Medication, American Association of Pharmaceutical Scientists Annual Meeting, Salt Lake City, UT, 2003.
  63. Ganguly, S. and Dash, A.K. Effect of Cross-linking on the In Vitro Release and Water Uptake in an In Situ Gel Delivery System, American Association of Pharmaceutical Scientists Annual Meeting, Salt Lake City, UT, 2003.
  64. Ganguly, S., Jayappa, S., Baisa, M.and Dash, A.K., Preparation and Characterization of Solid Dispersion of Creatine in Polyethylene Glycol, American Association of Pharmaceutical Scientists Annual Meeting, Salt Lake City, UT, 2003.
  65. Ganguly, S. and Dash, A.K., Development of a Sustained Release In Situ Gel Delivery System, American Association of Pharmaceutical Scientists Annual Meeting, Salt Lake City, UT, 2003.
  66. Amole, O. and Dash, A.K., Development of a Foam-Film Formulation the Treatment of Burns, Creighton University Summer Research Colloquium, August 5, 2004.
  67. Kosoko, A. and Dash, A.K., Dissolution Profiles of NSAID with Different Partition Coefficients, Creighton University Summer Research Colloquium, August 5, 2004.
  68. Jauhari, S. and Dash, A.K., Formulation and Evaluation of an Antibacterial Foam-Film System, AAPS Annual Meeting and Exposition 2004, Baltimore, MD, November 7-11, 2004.
  69. Jauhari, S. and Dash, A.K., A Mucoadhesive In Situ Gel Delivery System for Paclitaxel, AAPS Annual Meeting and Exposition 2004, Baltimore, MD, November 7-11, 2004.
  70. Jauhari, S., Dey, B. and Dash, A.K., Mechanism of Chemotherapy and Development of a Novel In Situ Gel Drug Delivery System for the Treatment of Colon Cancer, University of Nebraska Medical Center, July 19, 2004.
  71. Saini, T.S., Adeyemi, E., Boyce, A., Dash, A.K., and Parrish, L., An In Situ Gel Delivery System for Intracrevicular Medication (Poster # 2423), Annual meeting IADR/AADR/CADR, March 12, 2004, Honolulu, Hawaii.
  72. Fernandes, P., Maniar, M. and Dash, A. K., Preformulation Development of a Parenteral Formulation for ON 01210. Na, a Radioprotectant, AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  73. Fernandes, P., Maniar, M. and Dash, A. K. , Preformulation Development of a Parenteral Formulation for ON 01210.Na, a Radioprotectant, AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  74. Pathak, K., Jauhari, S. Saini, T. and Dash, A. K., Chitosan- hydroxyapatite Drug Delivery System in Root Canal Filling and Delivery .AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  75. Samineni, D., Pathak, K., Silberstein, P. T., and Dash, A. K., In Vitro Evaluation of Antiemetic Topical Gel Formulations in Cancer Chemotherapy AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  76. Jauhari, S. Kaushal, S. and Dash, A. K., Development and Characterization of a Sustained release Albendazole Delivery System for Colonic Delivery, AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  77. Jauhari, S. Kaushal, S. and Dash, A. K., A Simple LC Method for the Determination of Diethylcarbamazine Citrate, AAPS Annual Meeting and Exposition 2005, Nashville, TN, November 6-10, 2005.
  78. Trickler, W.J., Nagvekar, A.A., and Dash, A.K. In Vitro Biological Evaluation of a Surface-Modified Mucoadhesive Nanoparticulate Paclitaxel Delivery System for Breast Cancer Therapy, AAPS Annual Meeting and Exposition 2006, San Antonio, TX, October 29- November 2, 2006.
  79. Trickler, W.J., Nagvekar, A.A., and Dash, A.K., A Novel Surface-Modified Nanoparticulate Formulation for Sustained Drug Delivery and Targeting, AAPS Annual Meeting and Exposition 2006, San Antonio, TX, October 29-November 2, 2006.
  80. Trickler, W.J., Nagvekar, A.A., and Dash, A.K., Comparison of the Bio-Adhesive and Cellular Uptake Properties of Surface-Modified Nanoparticles, AAPS Annual Meeting and Exposition 2006, San Antonio, TX, October 29-November 2, 2006.
  81. Pathak K., Saini, T. and Dash, A.K., A Sustained-Release Local Drug Delivery System for Root Canal Filling, AAPS Annual Meeting and Exposition 2006, San Antonio, TX, October 29-November 2, 2006.
  82. Nagvekar, A.A, Trickler,W.J, and Dash,A.K, Development and Characterization of Nanoparticulate Delivery System for the Radioprotectant Drug Amifostine, AAPS Annual Meeting and Exposition 2006, San Antonio, TX, October 29-November 2, 2006.
  83. Trickler, W.J., and Dash, A.K., Gemcitabine Nanoparticles Consisting of Chitosan and Glycerol Monooleate for Pancreatic Cancer Treatment. AAPS Annual Meeting and Exposition 2007, San Diego, CA, November 9-November 15, 2007.
  84. Trickler, W.J., Nagvekar, A.A., and Dash, A.K., The Cellular Uptake and Sub-Cellular Localization of a Novel Nanoparticle Formulation for Breast Cancer Therapy. AAPS Annual Meeting and Exposition 2007, San Diego, CA, November 9-November 15, 2007.
  85. Trickler, W.J., and Dash, A.K, In Vivo Human Breast Cancer Comparison of the Effectiveness of Local Delivery Versus Systemic Administration of Novel Paclitaxel Nanoparticles. AAPS Annual Meeting and Exposition 2007, San Diego, CA, November 9- November 15, 2007.
  86. Nagvekar, A.A., Trickler, W.J., and Dash, A.K. Optimization of Nanoparticulate Sustained Drug Delivery Systems for Protection from Radioactive Exposure. AAPS Annual Meeting and Exposition 2007, San Diego, CA, November 9-November 15, 2007.
  87. Dash A.K. and Trickler W.J., Novel In Situ Gel Drug Delivery System for Breast Cancer Treatment, Era of Hope, Department of Defense Breast Cancer Research Meeting 2008, June 25-28, Baltimore Convention Center, Baltimore, Maryland.
  88. Jain, N., Munt, D., Trickler, W.J., and Dash, A.K. Preparation and Characterization of Melatonin and Amifostine Nanoparticles for Radioprotective Therapy. AAPS Annual Meeting and Exposition 2008, Atlanta, GA, November 16-November 20, 2008.
  89. Khurana, J., Trickler, W.J., Barr, C. and Dash, A.K. Fortified Orange Juice Affects the Trans-Epithelial Transport of Ciprofloxacin and Doxycycline. AAPS Annual Meeting and Exposition 2008, Atlanta, GA, November 16-November 20, 2008.
  90. Khurana, J., Trickler, W.J., Barr, C., Sahoo, S. and Dash, A.K. Development and Characterization of Polymeric Nanoparticulate Delivery Systems for Hydrophilic Drug: Gemcitabine. AAPS Annual Meeting and Exposition 2008, Atlanta, GA, November 16-November 20, 2008.
  91. Trickler, W.J. and Dash, A.K. The In Vivo Biodistribution and Tumor Efficacy of Paclitaxel Nanome™. AAPS Annual Meeting and Exposition 2008, Atlanta, GA, November 16-November 20, 2008.
  92. Jain, N., Khurana, J, and Dash, A.K., Development and Validation of a HPLC Method for Ciprofloxacin Hydrochloride to Establish a Beyond- use Date in Oral Suspension. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  93. Jain, N., Nagvekar, A., Pandit, A., and Dash, A.K. Development and Validation of a HPLC Method for Clonidine Hydrochloride to establish a Beyond-use Date in Oral Suspension. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8- November 12, 2009.
  94. Khurana, J., Beeson, T. , Stanley, A. , Dash, A.K. The effects of various additives and set accelerators on the physical and set properties of Mineral Trioxide Aggregate (MTA). AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  95. Jain, N., Hulce, M., Fusaro, R.M., Trickler, W.J. and Dash, A.K. Evaluation of the Permeability Characteristics of Lawsone and Juglone via Shed Snake Skin. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  96. Jain, N., Trickler, W. J., Munt, D. J., and Dash, A. K. Co-formulation of Melatonin and Amifostine Nanoparticles with Enhanced Radioprotection. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA,November 8-November 12, 2009.
  97. Trickler, W.J., Munt, D., Silber, M., Yusufov, T. and Dash, A.K. In Vitro cellular accumulation, transport and toxicity of Methylglyoxal. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  98. Munt, D.J., Silber, M., Yusufov, T., Dash, A.K. Evaluation of the Cytotoxicity of Methylglyoxal in Normal and Cancerous Cell Lines. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  99. Trickler, W.J., Nagvekar, A.A., and Dash, A.K. An In Vitro Evaluation of Fluorescent Nanoparticles and Their Sub-Cellular Localization. AAPS Annual Meeting and Exposition 2009, Los Angeles, CA, November 8-November 12, 2009.
  100. Trickler, W.J. and Dash, A.K. Development, Characterization, In vivo Biodistribution and Tumor Efficacy of Paclitaxel Nanome™. 11th Annual NIH SBIR/STTR Conference, Omaha, NE, June 30-July 1, 2009.
  101. Destache, C., Belgum, T., Shibata, A. And Dash, A.K., In Vivo Levels of Ritonavir (RTV), lopinavir (LPV), Efavirenz (EPV) Over Time After Intraperitoneal (IP) Injection of Antiretroviral (AR) PLGA Nanoparticles. Inter Science Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 2009.
  102. Pandit, A., Mistry, P., Dib, P., Nikolaidis, A., Dash, A.K., Equilibrium Solubility Studies of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  103. Pandit, A., Mistry, P., Dib, P., Nikolaidis, A., Dash, A.K., Chemical Stability of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine in Solution. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  104. Pandit, A., Mistry, P., Dib, P., Nikolaidis, A., Dash, A.K., Dissolution Profiles of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  105. Gupte, M.P., Dash, A.K., Effect of Drug Loading of Methylglyoxal on the Physicochemical Properties of GMO-Chitosan Nanoparticles. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  106. Kadajji, V., Dash, A.K., Polymeric Nanoparticles of Gamma Tocotrienol for Sustained Delivery in Radioprotective Therapy. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14- November 18, 2010.
  107. Hanna, P.A., Dash, A.K., Evaluation and Optimization of Alginate Microparticulate Delivery System for Drug Targeting. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  108. Hanna, P.A., Dash, A.K., Multiparticulate Alginate Delivery System for Targeting and Sustaining Drug via Oral Delivery. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14- November 18, 2010.
  109. Pandit, A., Dash, A.K., Development and Characterization of Sustained- Release Delivery System for Hydrophilic Drug: Ifosfamide. AAPS Annual Meeting and Exposition 2010, New Orleans, LA, November 14-November 18, 2010.
  110. Gupte, M.P., Dash, A.K., Effect of Cross-Linker on GMO/Chitosan Nanoparticulate System Containing a Hydrophilic Drug, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23- October 27, 2011.
  111. Mistry, P., Dash, A.K., Surface Modified Solid-Lipid Curcumin Nanoparticles for Oral Delivery, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  112. Chauhan, H., Mohapatra, S., Mistry, P., Munt, D., Dash, A.K., Physical Characterization of Glyceryl Monooleate (GMO) During Lyophilization Process, AAPS Annual Meeting and Exposition 2011,Washington DC, October 23-October 27, 2011.
  113. Mohapatra, S., Dash, A.K., Rheological Characterization of a Combinational Antiviral Vaginal Gel Formulation, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  114. Gupte, M.P., Dash, A.K., Development and Validation of an Efficient UPLC Method for the Analysis of Methylglyoxal, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  115. Munt, D., Fusaro, R., Hulce, M., Dash, A.K., Permeability of Dihydroxyacetone and its Effect on the Transport of Lawsone Across a Snake Skin Model for Stratum Corneum, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  116. Mohapatra, S., Mistry, P., Dash, A.K., A Novel Approach for the Preparation of a Stable GMO/Chitosan Nanoemulsion Containing Paclitaxel, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  117. Mohapatra, S., Kadajji, V.G., Goede, M., Destache, C.J., Dash, A.K., Combination Ativiral Vaginal Gels for Prophylactic Treatment of HIV-1, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  118. Mohapatra, S., Dash, A.K., Influence of High Pressure Homogenization, Hydrophobic Drug Load, and Stabilizers on the GMO/Chitosan Nanoemulsion Particle Characteristics, AAPS Annual Meeting and Exposition 2011, Washington DC, October 23-October 27, 2011.
  119. Munt, D., Dash, A.K.; Hulce, M.; Fussaro, R., Permeability of DHA and the Effect of DHA on the Permeability of Lawsone Across a Pig Skin, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14-October 18, 2012.
  120. Chandratre, S., Dash, A.K., Effect of Method of Preparation, and Stabilizer on the Stability of Glyceryl Monooleate-Chitosan Nanoemulsion, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14-October 18, 2012.
  121. Chandratre, S., Chauhan, H., Dash, A.K., Crystallization Inhibition of GMO-Chitosan Nanoparticles During Lyophilization Process, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14- October 18, 2012.
  122. Singh, V., Dash, A.K., Preparation, Characterization, and Evaluation of the Effect of Radiofrequency Application on Glyceryl-Monooleate (GMO)-Iron Oxide Nanoparticles, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14-October 18, 2012.
  123. Dhapare, S., Chandratre, S., Dash, A.K.,  Cellular Uptake and Cytotoxicity of Nanoparticles Containing Both Hydrophilic and Hydrophobic Drugs, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14-October 18, 2012.
  124. Dhapare, S., Dash, A.K., Fabrication and Characterization of PLGA Nanoformulation System Containing Both Hydrophobic and Hydrophilic Drugs, AAPS Annual Meeting and Exposition 2012, Chicago, IL, October 14-October 18, 2012.
  125. Dhapare, S., Dash, A.K., Further Studies on Preparation and Characterization of PLGA Nanoparticles Containing Hydrophobic and Hydrophilic Drugs, St. Albert’s Day Student Research Forum, Creighton University, March 26, 2013.
  126. Dhapare, S., Dash, A.K., Preparation and Characterization of Dual Function Nanoparticles Intended for Targeting Cancer Stem Cells, St. Albert’s Day Student Research Forum, Creighton University, March 26, 2013.
  127. Dhapare, S., Dash, A.K., Evaluation of Cellular Uptake, Cytotoxicity and Hemolytic Effects of PLGA Nanoparticles Containing a Combination of Anticancer Agents Paclitaxel and Gemcitabine, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10- 14, 2013.
  128. Dhapare, S., Dash, A.K., Development and Characterization of PLGA Nanoparticles Containing Paclitaxel and Gemcitabine for Combination Therapy, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10- 14, 2013.
  129. Chandratre, S., Dash, A.K., Preparation and Characterization of Multifunctional Solid-Lipid Nanoparticles for Cancer Therapy, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10-14, 2013.
  130. Grana, A., Munt, D., Dash, A.K., Preparation and Characterization of a Stable Microemulsion for Topical Application of DHA and Lawsone, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10- 14, 2013.
  131. Singh, V., Munt, D., Dash, A.K., Effect of External Radiofrequency on the In Vitro Release of Drug from Thermoresponsive Polymer Coated Iron Oxide Nanoparticles, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10- 14, 2013.
  132. Singh, V., Propst, S., Munt, D., Dash, A.K., Multifunctional Ethylcellulose Microparticles Containing Iron Oxide Nanoparticles for Hyperthermic Cancer Therapy, AAPS Annual Meeting and Exposition 2013, San Antonio, TX, November 10- 14, 2013.
  133. Munt, D., Dash, A.K. Development and Evaluation of Spray Pattern Analysis for Topical Dual Spray Formulations, AAPS Annual Meeting and Exposition 2013, San Diego, CA, November 3, 2014.
  134. Igor, M., Dash, A.K., Hulce, M., Smith, D. Direct Solid Phase Peptide Synthesis on Chitosan Microparticles for Tumor Targeting, AAPS Annual Meeting and Exposition 2013, San Diego, CA, November 6,2014.
  135. Dash, A.K., Pande, S. Preparation and Characterization of Multifunctional Chitosan Microparticles for Lung Delivery, AAPS Annual Meeting and Exposition 2013, San Diego, CA, November 6,2014.
  136. Dash, A.K., Grana, A., Munt, D., Rheological Examination of a Multiple Emulsion for Topical Application of Dihydroxyacetone and Lawsone, AAPS Annual Meeting and Exposition 2013, San Diego, CA, November 3, 2014.
  137. Dash, A.K., Grana, A., Munt, D., Characterization of a Multiple Emulsion for Topical Application of Dihydroxyacetone and Lawsone, AAPS Annual Meeting and Exposition 2013, San Diego, CA, November 3,2014.

C. Thesis/Dissertation:

Dash, A. K.: Studies on the utilization of rice bran wax in modern dermatological formulations, M. Pharm. Thesis, Jadavpur University, November 1983.
Dash, A. K.: Development of implantable polymeric drug delivery systems to treat bone infections, Ph.D. Thesis, University of Minnesota, December 1990.

D. Peer Reviewed Articles:

  1. Dash, A. K. and Suryanarayanan, R., A Liquid-Chromatographic Method for the Determination of Tobramycin. J. Pharm. Biomed. Anal., 9 (1991) 237-245.
  2. Dash, A. K. and Suryanarayanan, R., Solid-state Properties of Tobramycin, Pharm. Res., 8 (1991) 1159-1165.
  3. Dash, A. K. and Suryanarayanan, R., An Implantable Dosage Form for the Treatment of Bone Infections, Pharm. Res., 9 (1992) 993-1002.
  4. Dash, A. K., A Liquid Chromatographic Method for the Determination of Tolnaftate in Pharmaceutical Formulations, J. Pharm. Biomed. Anal., 11 (1993) 847-853.
  5. Dash, A. K., Determination of Pseudoephedrine HCl in Dosage Forms by Liquid Chromatography, J. Pharm. Biomed. Anal., 12 (1994) 1601-1606.
  6. Dash, A. K., Ndyetabula, W. A. and Ichwan, A. M., Use of Scanning Electron Microscopy to Study the Effect of Surfactant on the In Vitro Release of Valproic Acid from Coated Particles, Cells and Materials, 4 (1994) 331-336.
  7. Ichwan, A. M. and Dash, A. K., In Vitro Release of Valproic Acid from Coated Particles: Comparison of Various Dissolution Methods, Int. J. Pharm. Advances, 1 (1995) 64-72.
  8. Dash, A. K. and Harrison, J. S., An Ion-Pair Chromatographic Method for the Analysis of Mafenide Acetate, J. Chromatogr. A, 708 (1995) 83-88.
  9. Dash, A. K., Determination of the Physical State of Drug in Microcapsule and Microsphere Formulations, J. Microencap., 14 (1997) 101-112.
  10. Dash, A. K., and Tyle, P., Solid-State Characterization of AG337 (Thymitaq®), a Novel Antitumor Drug, J. Pharm. Sci., 85 (1996) 1123-1127.
  11. Dash, A. K. and Wong, S.-T., Liquid Chromatographic Method for the Determination of Nicotine in Pharmaceutical Formulations, J. Chromatogr. A, 749 (1996) 81-85.
  12. Haney, P. W. and Dash, A. K., Simple Liquid Chromatographic Method for the Analysis of 5-Aminosalicylic Acid and its Degradation Product, J. Chromatogr. A, 765 (1997) 233-239.
  13. Dash, A. K., Ion-Pairing Procedures Applicable to Drug Quality Control, Process Control and Quality, 10 (1997) 229-241.
  14. Destache, C. J., Pakiz, C. B., Dash, A. K. and Larsen, C., Nitric Oxide Concentrations and Cerebrospinal Fluid Parameters in an Experimental Animal Model of Streptococous pneumoniae meningitis, Pharmacotherapy, 18 (1998) 612-619.
  15. Dash, A. K., and Cudworth, G., Therapeutic Applications of Implantable Drug Delivery Systems, J. Pharmacol. Toxico. Method , 40 (1)(1998) 1-12.
  16. Zhao, P. and Dash, A. K., A Simple HPLC Method Using a Microbore Column for the Analysis of Doxorubicin, J. Pharm. Biomed. Anal. 20 (1999) 545-550.
  17. Dash, A. K., Gong, Z, Miller, D, Huai-yan, H. and Laforet, J-P, Development of a Rectal Nicotine Delivery for the Treatment of Ulcerative Colitis. Int. J. Pharm. 190 (1999) 21-34.
  18. Ichwan A. M., Karimi, M. and Dash, A. K., Use of Gelatin-Acacia Coacervate Containing Benzocaine in Topical Formulations, J. Pharm. Sci.88 (1999) 763-766.
  19. Owens, H.M., Destache, C. J. and Dash, A. K. Simple Liquid Chromatographic Method for the Analysis of the BBB Permeability Characteristics of Ceftriaxone in an Experimental Rabbit Meningitis Model,J. Chromatography B. 728 (1999) 97-105.
  20. Dash, A. K., Haney, P. W. and Garavallia, M. J., Development of an In Vitro Dissolution Method Using Microdialysis Sampling Technique for Implantable Drug Delivery Systems. J. Pharm. Sci., 88 (1999) 1036-1040.
  21. Fausett, H., Gayser, C. and Dash, A. K., Evaluation of Quick Disintegrating Calcium Carbonate Tablets, AAPS PharmSciTech, 2000, 1, article 20 (http://www.pharmscitech.com/).
  22. Dash, A.K., Miler, D. W., Huai-Yan, H, Carnazzo, J. and Stout, J. R., Evaluation of the Creatine Monohydrate Permeability Using Caco-2 Monolayers as an In Vitro Model for Intestinal absorption, J. Pharm. Sci., 90 (2001) 1593-1598.
  23. Fan, H. and Dash, A. K., Effect of Cross-linking on the In Vitro Release Kinetics of Doxorubicin From Gelatin Implants, Int. J. Pharm., 213 (2001) 103-116.
  24. Destache, C. J., Pakiz, C. B., Larsen, C., Owens, H. M. and Dash, A. K., Cerebrospinal Fluid Penetration and Pharmacokinetics of Levofloxacin in an Experimental Rabbit Meningitis Model with Penicillin Sensitive Pneumococcus, J. Antimicrob. Chemother., 47 (2001) 611-615.
  25. Dash, A. K., and Cudworth, G. Evaluation of an Acetic Acid Ester of Monoglyceride as a Suppository Base with Unique Properties. AAPS PharmSci Tech., 2 (2001) Article 14. http://www.pharmscitech.com/).
  26. Dash, A. K., Mo, Y., and Pyne, A., Solid-State Properties of Creatine Monohydrate, J. Pharm. Sci., 91 (2002) 708-718.
  27. Pham, H. H., Luo, P., Genin, F. and Dash, A. K., Synthesis and Characterization of Hydroxyapatite-Ciprofloxacin Delivery Systems by Precipitation and Spray Drying Technique, AAPS PharmSci Tech. 3 (2002) Article 1. http://www.pharmscitech.com/).
  28. Chigurupati, N., Saiki, L. and Dash, A. K., Evaluation of Red Cabbage Dye as a Potential Natural Color for Pharmaceutical Use, Int. J. Pharm., 241 (2002) 293-299.
  29. Dash, A. K. and Sawhney A., A Simple LC Method with UV Detection for the Analysis of Creatine and Creatinine and its Application to Several Creatine Formulations, J. Pharm. Biomed. Anal., 29 (2002) 939-945.
  30. Dash, A. K., Khin-Khin, and Suryanarayanan, R., X-Ray Powder Diffractometric Method for Quantification of Crystalline Drug in Microparticulate Systems I: Microspheres. J. Pharm. Sci., 91 (2002) 983- 990.
  31. Mo, Y., Dobberphul, D. and Dash, A. K., A Simple HPLC Method with Pulsed EC Detection for the Analysis of Creatine, J. Pharm. Biomed. Anal., 32 (2003) 125-132.
  32. Ganguly, S., Jayappa, S. and Dash, A.K. Evaluation of the Stability of Creatine in Solutions Prepared from Effervescent Creatine Formulations, AAPS PharmSciTech 2003; 4 (2) Article 26 (http://www.pharmscitech.org).
  33. Dash, A.K. and Elmquist, W.F., Separation Methods that are Capable of Revealing Blood-Brain Barrier Permeability, J. Chromatography B, 797(2003) 241-254.
  34. LeDays, A.M., Ganguly, S., Kulakarni, K.H., Dash, A.K., Opere, C.A. and Ohia, S.E., Efect of Hydrogenperoxide on Aminoacid Concentrations in Bovine Retina and Vitreous Humor, Ex Vivo, Methods Find Exp Clin Pharmacol. 25 (2003) 695-701.
  35. Ganguly, S. and Dash, A.K., A Novel In Situ Gel for Sustained Drug Delivery and Targeting, Int. J. Pharma. 276 (2004) 83-92.
  36. Panyam, J., Williams, D., Dash, A.K., Leilie-Pelecky, D. and Labhasetwar, V., Solid-state Solubility Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles, J. Pharm. Sci., 93 (2004) 804-1814.
  37. LeDay, A.M., Awe, S.O., Kulkarni, K.K., Harris, L., Opere, C., Dash, A.K., and Ohia, S.E., Effect of Peroxide on [3H]D-Aspartate Release from Bovine Isolated Retina, Neurochemical Research, 29 (2004) 811-818.
  38. Jauhari, S. and Dash, A.K., A Mucoadhesive In-Situ Gel Delivery System for Paclitaxel, AAPS PharmSciTech 2006; 7 (2) Article 53
  39. Hamilton, W.R., Dash, A.K., Meyer, J.M.S., and Spicka, S.J., Use of Probiotics in the Management of Antbiotic-Associated Diarrhea, Pharmacy Times, November, 2006, 147-155.
  40. Fernandes, P., Maniar, M., and Dash, A.K., Development and Validation of a Sensitive Liquid Chromatographic Method for the Analysis of a Novel Radioprotectant: ON 01210.Na, J. Pharm. Biomed. Anal., 43 (2007) 1796- 1803.
  41. Trickler, W.J., Nagvekar, A.A., and Dash, A.K., A Novel Nanoparticle Formulation for Sustained Paclitaxel Delivery, AAPS PharmSciTech 2008 Mar. 18.
  42. Singh, S. and Dash, A.K., Radioprotectants: Basic concepts, current status, and future directions, Drugs of the Future. 33 (2008) 681-689.
  43. Nagvekar, A., Trickler, W. and Dash, A.K., Current Analytical Methods Used in the In Vitro Evaluation of Nano-Drug Delivery Systems, Curent Pharmaceutical Analysis 5 (2009) 358-366.
  44. Trickler, W., Nagvekar, A., Dash A.K., The In Vitro Sub-cellular Localization and In Vivo Efficacy of Novel Chitosan/GMO Nanostructure Containing Paclitaxel. Pharm. Res. 26 (2009) 1963-1973.
  45. Trickler, W., Munt, D.J, Jain, N., Dash A.K., Tumor Distribution and Blood Pharmacokinetics of Chitosan/Glyceryl –Monooleate Nanostructure Containing Paclitaxel Compared to a Conventional Paclitaxel Formulation,. Nanomedicine. 6 (2011) 437-448.
  46. Nagvekar, A., Trickler, W. and Dash, A.K., Chitosan and Glyceryl Monooleate Nanostructures Containing Gemcitabine: Potential Delivery System for Pancreatic Cancer Treatment. AAPSPharmSciTech (March 18, 2010) DOI: 10.1208/s12249-010-9393-0.
  47. Destache, C.J., Belgum, T., Christensen, K, Shibata, A, Sharma, A. and Dash, A.K., Combination Antiretroviral Drugs in PLGA Nanoparticle for HIV-1. BMC Infectious Diseases 2009, 9:198.
  48. Singh, S. and Dash, A.K., Paclitaxel in cancer treatment: Perspectives and Prospects of its Delivery Challenges, Critical Reviews in Therapeutic Drug Carrier Systems. 26 (2009) 333-372.
  49. Dash, A.K., The Dark Side of Paclitaxel, Oncol Rev, 4 (2010) 71-72.
  50. Pandit A. A. and Dash, A.K., Surface modified solid lipid nanoparticulate formulation for Ifosfamide: Development and Characterization, Nanomedicine. 6 (2011) 1397-1412.
  51. Mistry, P., Mohapatra, S. and Dash, A.K., Effect of High Pressure Homogenization and Stabilizer on the Physicochemical Properties of Curcumin Loaded GMO/Chitosan Nano Structure. Nanomedicine , 7 (2012) 1863-1876.
  52. Chandratre, S. and Dash, A.K., Multifunctional Nanoparticles for Prostate Cancer Therapy. AAPSPharmSciTech (September 9, 2014) DOI: 10.1208/s12249-014-0202-z.
  53. Dhapare S. and Dash, A.K., Effect of Differential Drying Techniques on PLGA Nanoparticles Containing Hydrophobic and Hydrophilic Anticancer Agents, Ther. Deliv. 6 (2015) 27-39.

E. Book Reviews:

  1. "Recent Advances in Pharmaceutical and Industrial Biotechnology", A. Hincal and H. Suheyla Kas eds, Editions de Sante, Rue Las Cases, Paris (1993). Reviewed for Pharm. Research (1993).
  2. "Stability Testing in the EC, Japan and the USA, Scientific and Regulatory Requirements", W. Grimm and K. Krummen eds, Wiss. Verl., Stuttgart, Germany. Reviewed for Pharm. Research (1994).
  3. A. K. Dash and S. Venkatesh, "Polymeric Biomaterials", S. Dumitriu ed, Marcel Dekker Inc., New York, NY (1993). Reviewed for Pharm. Research (1995).
  4. “Neutraceuticals,” Lisa Rapport and Brian Lackwood, Pharmaceutical Press, London, Reviewed for J. Pharmacy and Pharmacology, 55 (2003) 275- 276.

F. Chapters in Texts:

  1. Dash, A. K., "Tolnaftate" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA., Volume 23 (1994) pp. 543-570.
  2. Dash, A. K. and Shah, S. L., "Mafenide Acetate" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA., Volume 24 (1996) pp. 277-305.
  3. Dash, A. K., "Tobramycin" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA., Volume 24 (1996) pp. 579-613.
  4. Dash, A. K. and Brittain, H.G., "5-Aminosalicylic acid" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA., Volume 25 (1997) pp. 209-242.
  5. Dash, A. K. and Elmquist, W. F., "Fluconazole" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA., Volume 27 (2001) pp. 67-113.
  6. Dash, A.K., "Ionic Equilibria" in Applied Physical Pharmacy, McGraw-Hill Companies, NY, 2003, pp.67-97.
  7. Dash, A. K., and Owens, H. "Ceftriaxone Sodium" in Analytical Profiles of Drug Substances, Excipients and Related Methodology: Edited by H. Brittain, ed., Elsevier Academic Press, NY, 2003, 21-59.
  8. Rostoui, H. and Dash, A.K., Microdialysis and its Applications in Bioavailability Studies, in Bioavailability and Bioequivalence in Pharmaceutical Technology, Edited by T. K. Pal and M. Ganesan, CBS Publishers and Distributors, New Delhi, India, 2004, 53-79.
  9. Dash, A. K., and Singh, S. "Creatine Monohydrate" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA, Volume 34 (2009) pp. 1-37.
  10. Dash, A. K., Jouhari, S. and Singh, S. "Paclitaxel" in Analytical Profiles of Drug Substances and Excipients: Edited by H. Brittain, ed., Academic Press, San Diego, CA, Volume 34 (2009) pp. 299-339.
  11. Dash, A.K., Khurana, J., Singh, S., Multiple Emulsions: An overview and Pharmaceutical Applications in Colloids in Pharmaceutical and Biotechnological Applications, Edited by Monzer Fanun, Ph.D. CRC Press, 2010, Surfactant Science Series, Vol. 148, pp. 177-202.
  12. Singh S. and Dash, A.K., Chapter 3: Physical Properties, Their Determination and Importance in Pharmaceutics, in Pharmaceutics: Basic Principles and Application to Pharmacy Sciences (2013), Eds. AK Dash, S Singh and J Tolman, Elsevier, MA, USA , pp.51-84.
  13. Dash, A.K., Chapter 7: Drug, Dosage Form and Drug Delivery Systems, in Pharmaceutics: Basic Principles and Application to Pharmacy Sciences (2013), Eds. AK Dash, S Singh and J Tolman, Elsevier, MA, USA , pp.153- 159.
  14. Dash, A.K., Chapter 8: Solid Dosage Forms, in Pharmaceutics: Basic Principles and Application to Pharmacy Sciences (2013), Eds. AK Dash, S Singh and J Tolman, Elsevier, MA, USA , pp.161-180.
  15. Mohapatra, S.K. and Dash, A.K., Chapter 12: Special Dosage Forms and Drug Delivery Systems, in Pharmaceutics: Basic Principles and Application  to Pharmacy Sciences (2013), Eds. AK Dash, S Singh and J Tolman, Elsevier, MA, USA , pp.273-303.

 

 

 

 

 

 

 

 

Alekha K Dash, RPh, PhD

Professor and Chair
Sciences Creighton University
Omaha, Nebraska, USA
Phone: (402) 492-9707,
E-mail: adash@creighton.edu